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Abstract
Background: The central nervous system (CNS) is extremely vulnerable to ischemic injury. The
details underlying this susceptibility are not completely understood. Since the CNS is surrounded
by cerebrospinal fluid (CSF) that contains a low concentration of plasma protein, we examined the
effect of changing the CSF in the evolution of CNS injury during ischemic insult.
Methods: Lumbar spinal cord ischemia was induced in rabbits by cross-clamping the descending
abdominal aorta for 1 h, 2 h or 3 h followed by 7 d of reperfusion. Prior to ischemia, rabbits were
subjected to the following procedures; 1) CSF depletion, 2) CSF replenishment at 0 mmHg
intracranial pressure (ICP), and 3) replacement of CSF with 8% albumin- or 1% gelatin-modified
artificial CSF, respectively. Motor function of the hind limbs and histopathological changes of the
spinal cord were scored. Post-ischemic microcirculation of the spinal cord was visualized by
fluorescein isothiocyanate (FITC) albumin.
Results:  The severity of histopathological damage paralleled the neurological deficit scores.
Paraplegia and associated histopathological changes were accompanied by a clear post-ischemic
deficit in blood perfusion.
Spinal cord ischemia for 1 h resulted in permanent paraplegia in the control group. Depletion of
the CSF significantly prevented paraplegia. CSF replenishment with the ICP reduced to 0 mmHg,
did not prevent paraplegia. Replacement of CSF with albumin- or gelatin-modified artificial CSF
prevented paraplegia in rabbits even when the ICP was maintained at 10–15 mmHg.
Conclusion: We conclude that the presence of normal CSF may contribute to the vulnerability of
the spinal cord to ischemic injury. Depletion of the CSF or replacement of the CSF with an albumin-
or gelatin-modified artificial CSF can be neuroprotective.
Background
The central nervous system (CNS) including brain and
spinal cord is extremely susceptible to hypoxic-ischemic
insults compared with peripheral organ systems such as
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the liver, kidney, lung, or intestines. The mechanism
underlying this susceptibility is not completely under-
stood. Many theories have been proposed and intensively
investigated, including the involvement of oxygen free
radicals, calcium overloading, excitatory amino acid
release and nitric oxide [1-3]. These various mechanisms,
however, have not been proven conclusively to mediate
the vulnerability of the brain and spinal cord to ischemic
injury.
In peripheral organ systems, capillaries are relatively per-
meable to proteins. The associated lymphatic system
maintains lymph and interstitial fluid (ISF) protein con-
centration at about 2 g/dl, and ensures a negative intersti-
tial pressure at about -3 mmHg [4]. In the CNS, the brain
and spinal cord are bathed by the cerebrospinal fluid
(CSF). Although the CSF system has similarities with the
lymphatics, the CSF contains only about 25 mg/dl of pro-
tein [5]. In addition, intracranial pressure (ICP) averages
about 10 mmHg, resulting in a positive interstitial fluid
pressure [4], in contrast to the negative pressure in periph-
eral tissues. Hence, the CSF system may predispose the
CNS to edema. Swelling of cerebral tissue can compress
blood vessels inside the Virchow-Robin space leading to a
persistent deficit in blood perfusion even after the restora-
tion of blood perfusion, termed a 'no-reflow' or 'low
reflow' phenomenon [6]. We therefore hypothesized that
the presence of CSF and a positive ICP may explain why
the CNS is more vulnerable to ischemia than peripheral
organ systems.
The spinal cord has a linear contour, it is therefore possi-
ble to create a CSF free environment for the lumbar spinal
cord by removing the CSF and adjusting body position.
Using a rabbit model of spinal cord ischemia, this investi-
gation distinguished the influence of the CSF from that of
ICP, and demonstrated that the addition of albumin or
gelatin to the CSF can prevent injury and may be
neuroprotective.
Methods
Male New Zealand white rabbits, n = 77, weighing 2.5–3
kg were used (Harlan, Indiana). Animal studies were
approved by the institutional animal care and use com-
mittee (permission number 2249) and complied with the
'Principles of Laboratory Animal Care' (Guide for the Care
and Use of Laboratory Animals, National Institute of
Health publication 86-23, 1985).
Pre-ischemia preparation
Each rabbit was anesthetized with isoflurane in 100%
oxygen (5% for induction, 1% for maintenance) by face-
mask. Body temperature was maintained at 37 ± 1°C with
a heating blanket. The right femoral artery was catheter-
ized for monitoring mean arterial pressure (MAP) and for
acquiring samples for blood gas analysis during surgical
procedures. To remove the CSF and to monitor the ICP, a
small silicon tube (OD = 0.025, ID = 0.012 inches,
Braintree Scientific, MA) was placed in the cisterna
magna. Briefly, an incision was made on the dorsal neck
to expose the nuchal ridge and dorsal cervical muscula-
ture. The atlanto-occipital membrane was exposed by
blunt dissection and pierced with a 30 gauge needle. The
silicon tube was twisted gently through the hole on the
membrane until CSF was noted to pulsate in the catheter.
The tube was fixed in position and immobilized to the
adjacent muscle by an instant adhesive cyanoacrylate gel
(Plastics One, VA). To facilitate removal of the CSF and to
administer albumin- and gelatin-modified artificial CSF
another silicon tube was placed in the lumbar subarach-
noid space. Briefly, a laminectomy was carried out at sac-
rococcygeal level to expose the lumbar subarachnoid
space. The dura was then pierced with a 30 gauge needle.
The tube was twisted gently into subarachnoid space
through the dura and immobilized with the same adhe-
sive to the adjacent muscle.
Experimental design
Rabbits were randomly divided into 7 groups.
Group 1. Control group (n = 12)
No treatment was given. The ICP was monitored through
the small silicon tube in the cisterna magna and main-
tained at 10 – 15 mmHg by withdrawing or infusing CSF
through the tube in lumbar subarachnoid space. Rabbits
were subjected to 1 h spinal cord ischemia.
Group 2. CSF depleted group (n = 12)
The objective was to provide the ischemic spinal cord with
a relatively CSF free environment. Prior to spinal cord
ischemia, the CSF was removed as completely as possible;
usually 0.8 – 1.2 ml CSF could be withdrawn. To assist in
maintaining a CSF free environment below the lumbar
spinal cord, two additional procedures were used. First,
while the tube in the cisterna magna was withdrawing
CSF, the tube in lumbar subarachnoid space was kept
open. Second, after removing the CSF, rabbits were kept in
a tilted position with the head down (10 degrees) to pre-
vent any remaining CSF from flowing to the lumbar
region during the period of ischemia. After CSF depletion,
rabbits were subjected to 1 h spinal cord ischemia. The
ICP was monitored and maintained at 0 mmHg during
the period of ischemia.
Group 3. CSF replenished group (n = 12)
The objective was to provide the ischemic spinal cord with
a normal CSF environment while maintaining ICP at 0
mmHg. Prior to spinal cord ischemia, the CSF was
removed as completely as possible as described above. To
ensure that CSF was present in the lumbar spinal cordCerebrospinal Fluid Research 2005, 2:7 http://www.cerebrospinalfluidresearch.com/content/2/1/7
Page 3 of 12
(page number not for citation purposes)
ischemic region, two procedures were used. First, 0.1 ml
CSF was immediately replenished through the tube in the
lumbar subarachnoid space. This volume was previously
determined by withdrawing CSF post mortem from a rabbit
weighing 2.5 kg. Second, rabbits were kept in a tilted posi-
tion with head up (10 degrees) during the period of
ischemia to allow any remaining CSF inside cranium to
flow into the ischemic region of the spinal cord. After CSF
replenishment, the rabbits were subjected to 1 h spinal
cord ischemia. The ICP was monitored and maintained at
0 mmHg.
Group 4. Albumin-modified artificial CSF group (n = 12)
The objective of this group was to replace the CSF with
albumin-modified artificial CSF in the spinal subarach-
noid space. Albumin-modified artificial CSF was made by
dissolving 8% bovine albumin (A6003, Sigma-Aldrich) in
artificial CSF (Na+ 150 mEq/L, K+ 3.0 mEq/L, Mg++ 0.9
mEq/L, Ca++ 1.4 mEq/L, P 1.0 mEq/L, Cl- 155 mEq/L, glu-
cose 60 mg/dl). Prior to spinal cord ischemia, 2 ml of
albumn-modified artificial CSF was quickly flushed in
through the silicon tube in the lumbar subarachnoid
space and allowed to flow out through the tube in the cis-
terna magna. Rabbits were then subjected to 1 h spinal
cord ischemia, during which time albumin-modified arti-
ficial CSF was continuously infused at rate of 2 ml/h. The
ICP was monitored and maintained at 10–15 mmHg dur-
ing the infusion by withdrawing or infusing the albumin-
modified artificial CSF from the lumbar subarachnoid
space.
Group 5. Gelatin-modified artificial CSF treatment group (n = 12)
The objective of this group was to replace the CSF with gel-
atin-modified artificial CSF in the spinal subarachnoid
space and to compare it with albumin-modified artificial
CSF. Gelatin-modified artificial CSF was made by dissolv-
ing 1% porcine skin gelatin (G1890, molecular weight
between 50,000 – 100,000, Sigma-Aldrich) in artificial
CSF. The experiment was performed as described for
group 4.
Group 6. (n = 10)
Treatment was the same as group 2, except that all rabbits
were subjected to 2 h spinal cord ischemia and the CSF
removal procedure was repeated every h.
Group 7. (n = 7)
Treatment was the same as group 2, except that all rabbits
were subjected to 3 h spinal cord ischemia and the CSF
removal procedure was repeated every h.
Induction of ischemia
After the treatment according experimental design, spinal
cord ischemia was induced according to Zivin [7]. Under
aseptic operative techniques, a midline abdominal
laparotomy of 6–7 cm long was made and the intrarenal
aorta was isolated. A Diethrich bulldog clamp (50 mm
length, closing force 50 g) was used to cross-clamp the
aorta just caudal to the left (lower) renal artery. In the rab-
bit, this corresponds to the second lumbar vertebrae (L 1–
2) level. The aorta was cross-clamped for 1, 2 and 3 h
according to the experimental design. Immediately after
the removal of the clamp, the abdominal incision was
closed in layers. After ischemia, all silicon tubes were dis-
connected, and the wounds were closed. Rabbits were
returned to their cages, provided food and water and
allowed to recover for seven days.
Neurological deficit evaluation
After ischemic injury, each rabbit was tested daily for
seven days. Motor function of the hind limbs was scored
from 0 – 5 according to modified Tarlov's score [8] by an
investigator blinded to the experimental group. Score 0:
complete recovery, able to hop normally (the hind limbs
were able to leave the ground simultaneously when hop-
ping). Score 1: able to hop but wobbly and might fall on
their side occasionally. Score 2: able to stand, but unable
to hop; Score 3: good movement of the hind limbs, but
unable to stand; Score 4: spastic paraplegia with slight
movement of the hind limbs; Score 5: spastic paraplegia
with no movement to the hind limbs. An animal with a
motor function (Tarlov score) ≥ 2 was considered
paraplegic.
Histopathological evaluation
After seven days of neurological evaluation, rabbits were
euthanized with an overdose of pentobarbital sodium
(200 mg/kg) injection via the heart. The spinal cord was
perfused with 10% buffered formalin. The spinal cords
from lower thoracic level to the lower lumbar level were
harvested by multiple laminectomies and fixed in a 10%
buffered formalin solution for one week. Spinal cord seg-
ments at the lumbar enlargement were embedded in par-
affin. Transverse sections were cut at 6 µm and stained
with hematoxylin-eosin. The spinal cord lesions at L5
level were scored under the microscope at a magnification
of 40× and 100× by an investigator blinded to experimen-
tal procedures according to the following criteria [9-11]:
Score 1: Number of vacuolations < 5 in grey matter of the
hemi-section.
Score 2: Number of vacuolations ≥ 5 in grey matter of the
hemi-section.
Score 3: The architecture of grey matter was necrotic or
completely destroyed or replaced by scar tissue. No neu-
rons could be seen.Cerebrospinal Fluid Research 2005, 2:7 http://www.cerebrospinalfluidresearch.com/content/2/1/7
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Visualization of the spinal cord microcirculation
At 23 h after spinal cord ischemia, lumbar spinal cord
microcirculation was studied in two rabbits from groups
1–5. Each rabbit received 0.3 g/kg 15% fluorescein isothi-
ocyante (FITC) albumin (Sigma-Aldrich) by i.v. bolus
injection [12]. Rabbits were euthanized 2 min after FITC
injection by the method described above. Spinal cords
were immediately removed and fixed in 10% formalin
overnight and transferred to 25% sucrose for 24 h. The tis-
sues were frozen with dry ice. Transverse sections, 100 µm
thick, were cut with a microtome at the level of L5, trans-
ferred to glass slides and investigated immediately by flu-
orescence microscopy at 40× magnification.
Statistical analysis
The physiological parameters were analyzed with one-way
repeated measures ANOVA (analysis of variance) fol-
lowed by Tukey test. The neurological deficit scores and
the histopathological scores were analyzed with Kruskal-
Wallis ANOVA on Ranks followed by the Tukey test. A p
value < 0.05 was considered statistically significant.
Results
Physiological parameters at baseline and reperfusion were
similar for all experimental groups and there were no sig-
nificant differences between groups. In addition, there
were no significant differences between baseline and
reperfusion values for MAP, PO2, PCO2, pH and glucose
in any group (Table 1).
The neurological deficit score, taken 24 h after ischemia
did not differ from the score obtained seven days after
ischemia. Control animals subjected to 1 h of spinal cord
ischemia demonstrated permanent paraplegia (100% par-
aplegic rate, Fig. 1A, group 1-closed circles). The CSF deple-
tion with the ICP maintained at 0 mmHg prevented the
development of paraplegia (0% paraplegic rate, Fig. 1A,
group 2-open circles). However, replenishment of CSF
around ischemic spinal cord (returning a small amount of
CSF while maintaining a tilted, head-up position) did not
prevent paraplegia, even when the ICP was controlled at 0
mmHg (100% paraplegic rate, Fig. 1A, group 3-closed tri-
angles). Replacing the CSF with albumin- or gelatin-mod-
ified artificial CSF under physiological ICP conditions
(10–15 mmHg) significantly prevented the development
of paraplegia (~20% paraplegic rate, Fig. 1A, groups 4-
open triangles, and 5-closed squares).
Similarly, the CSF depletion significantly prevented para-
plegia in rabbits subjected to 2 h of spinal cord ischemia
(~30% paraplegic rate, Fig. 1A, group 6-open squares), but
did not significantly prevent paraplegia after 3 h of
ischemia (100% paraplegic rate, Fig. 1A, group 7-closed
diamonds).
Table 1: Physiologic parameters during rabbit spinal cord ischemia. Values are mean ± SD. Baseline physiological values were 
determined 5 minutes before cross-clamping the aorta. Reperfusion physiological values were determined 5 minutes after releasing 
the clamp around abdominal aorta. None of the physiological parameters at baseline and reperfusion differed significantly between 
the various experimental groups. There were no significant differences in MBP, PO2, PCO2 and glucose between baseline and 
reperfusion in any group. The pH value was slightly decreased after ischemia in each group, however, there were no significant 
differences either.
Group
1234567
Variable n = 10 n = 10 n = 10 n = 10 n = 10 n = 10 n = 7
MAP (mmHg)
Baseline 82 ± 12 83 ± 11 86 ± 12 76 ± 7 84 ± 14 79 ± 11 81 ± 15
Reperfusion 80 ± 8 81 ± 11 81 ± 10 76 ± 11 78 ± 14 74 ± 11 73 ± 9
pH
Baseline 7.40 ± 0.03 7.41 ± 0.03 7.40 ± 0.03 7.39 ± 0.02 7.39 ± 0.02 7.40 ± 0.03 7.40 ± 0.03
Reperfusion 7.35 ± 0.02 7.34 ± 0.03 7.35 ± 0.05 7.34 ± 0.03 7.35 ± 0.04 7.33 ± 0.02 7.33 ± 0.03
PaO2 (mmHg)
Baseline 212 ± 19 221 ± 18 225 ± 24 208 ± 22 213 ± 20 226 ± 18 223 ± 24
Reperfusion 225 ± 26 209 ± 20 223 ± 20 212 ± 20 225 ± 21 230 ± 14 234 ± 31
PaCO2 (mmHg)
Baseline 38 ± 3 37 ± 4 38 ± 2 37 ± 3 39 ± 2 37 ± 2 37 ± 3
Reperfusion 35 ± 7 35 ± 3 36 ± 5 35 ± 5 36 ± 3 35 ± 4 34 ± 5
Glucose (mg/dl)
Baseline 131 ± 22 133 ± 27 123 ± 26 128 ± 29 141 ± 25 121 ± 30 126 ± 25
Reperfusion 134 ± 22 143 ± 25 117 ± 24 138 ± 30 144 ± 25 128 ± 26 135 ± 30Cerebrospinal Fluid Research 2005, 2:7 http://www.cerebrospinalfluidresearch.com/content/2/1/7
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Effect of CSF removal and replacement of CSF with albumin- and gelatine-modified artificial CSF on rabbit spinal cord ischemia Figure 1
Effect of CSF removal and replacement of CSF with albumin- and gelatine-modified artificial CSF on rabbit 
spinal cord ischemia. Group 1 (closed circles). 1 h ischemia; prior treatment: none; ICP: 10–15 mmHg. Group 2 (open cir-
cles). 1 h ischemia; prior treatment: CSF depleted; ICP: 0 mmHg. Group 3 (closed triangles). 1 h ischemia; prior treatment: CSF 
replenished; ICP: 0 mmHg. Group 4 (open triangles). 1 h ischemia; prior treatment: 8% albumin in artificial CSF; ICP: 10–15 
mmHg. Group 5 (closed squares). 1 h ischemia:; prior treatment: 1% gelatin in artificial CSF; ICP: 10–15 mmHg. Group 6 (open 
squares). 2 h ischemia; prior treatment: CSF depleted; ICP: 0 mmHg. Group 7 (closed diamonds). 3 h ischemia; prior treat-
ment: CSF depleted; ICP: 0 mmHg. A. Neurological deficit (Tarlov score) determined at 7 d after spinal cord ischemia. Group 
1 vs. groups 2, 4, 5 and 6; Group 3 vs group 2, 4 and 5; Group 7 vs. group 2 and 5 are significantly different when analyzed by 
Kruskal Wallis ANOVA followed by Dunn's test (p < 0.05). B. Histopathological score determined at 7 d after spinal cord 
ischemia by H&E staining. Groups 1, 3 and 7 vs. Groups 2, 4, 5 and 6 were significantly different analyzed by Kruskal Wallis 
ANOVA followed by Dunn's test (p < 0.05).Cerebrospinal Fluid Research 2005, 2:7 http://www.cerebrospinalfluidresearch.com/content/2/1/7
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In all groups, the scores for the severity of the histopatho-
logical damage paralleled that for the neurological deficits
(Fig 1B). Typical histopathological findings following spi-
nal cord ischemia included necrosis and vacuolation of
the neuropil in the grey matter. Without CSF removal, the
severe necrosis often destroyed normal architecture of the
grey matter resulting in liquefaction (Fig 2A). The deple-
tion of CSF, replacement of CSF with albumin- or gelatin-
modified artificial CSF prevented signs of histopathologi-
cal damage (Fig 2B&C). In contrast, the replenishment of
CSF around ischemic spinal cord resulted in necrosis or
severe vacuolation of grey matter (Fig 2D&E).
Normal microcirculation of the spinal cord when visual-
ized by FITC-albumin demonstrated good capillary filling
with clear contrasting of fluorescein signals between grey
and white matter (stronger in grey matter than in white
matter). After ischemia the 'no-reflow' phenomenon was
characterized by the absence of capillary filling in both the
grey matter and white matter. A 'no-reflow' phenomenon
of lumbar spinal cord was demonstrated in control rab-
bits (Fig 3A). In contrast, normal microcirculation of lum-
bar spinal cord was observed after ischemia in rabbits
with the depletion of CSF, or replacement of CSF by albu-
min- or gelatin-modified artificial CSF (Fig 3B,D&E). The
'low-reflow' phenomenon was also noticed in rabbits
with the replenishment of CSF (Fig 3C).
Discussion
The CNS lacks a lymphatic system; instead it is sur-
rounded by the CSF. The CSF is very different from the
lymph in peripheral tissues in at least two aspects: protein
concentration and the resultant interstitial fluid pressure.
In peripheral tissues, capillaries are relatively permeable
and as a result the ISF contains about 2 g/dl of plasma pro-
teins. It is believed that interstitial proteins and
hyaluronic acids form a dense network of proteoglycan
filaments that impede fluid flow through the interstitium.
Normally the amount of free-flowing fluid, present in the
interstitium is small. A low interstitial protein concentra-
tion results in an increased amount of free ISF. An ele-
vated concentration of interstitial protein may reduce the
free ISF, but it also attracts more fluid, resulting in
increased volume. The lymphatic system is the scavenging
pathway for interstitial proteins. By regulating the
removal of excess protein, the lymphatic system keeps the
interstitial protein concentration around 2 g/dl. This
ensures limited free fluid and also regulates the ISF vol-
ume. Lymph flow reduces ISF volume resulting in nega-
tive interstitial pressure. Therefore, the movement of
proteins from plasma to ISF and finally to lymph is
important for maintaining extracellular homeostasis.
In the CNS, the CSF is secreted by the choroid plexuses
that line the cerebral ventricles. Tight junctions linking the
adjacent choroidal epithelial cells form the blood-CSF
barrier and prevent most large molecules from passing
into the CSF from the blood. Therefore the CSF contains
an extremely low protein concentration. The choroid plex-
uses may not be the only sites for CSF production. Milho-
rat reported that in monkeys with choroid plexuses
removed, up to 60% of the CSF is produced from ISF flow
out of the brain [13]. The ISF has a bulk flow rate of 0.1–
0.3  µl/min/g in rat brain along preferential pathways
especially the Virchow-Robin spaces and axon tracts [14].
Formation of ISF is thought to occur by active transport
processes at the cerebral capillary [15]. The blood-brain
barrier (BBB) prevents proteins from entering the intersti-
tium. Therefore, it is speculated that the ISF in brain, just
like the CSF, has a low protein concentration. It is esti-
mated that intracellular protein concentration averages
about 16 g/dl in mammalian cells [4]. Therefore water
and Na+ in the ISF have the potential to move easily into
cells. More importantly, the CSF is contiguous with the
ISF, with the Virchow-Robin spaces, serving as a conduit.
To make matters worse, the ICP averages about 10 mmHg
leading to a positive interstitial fluid pressure. Taken
together, these factors make the CNS prone to edema for-
mation. As a result cells in the CNS constantly consume
energy to remove excess intracellular fluid in physiologi-
cal condition. When cell energy is compromised, such as
in ischemia, or when the cell membrane is damaged by
direct trauma, cells rapidly become swollen, i.e. cytotoxic
edema (Fig 4).
By taking advantage of the linear contour of the spinal
cord, we were able to verify the role of CSF independently
of the influence of ICP. All rabbits in the control group
developed permanent paraplegia, necrosis of grey matter
and associated 'no-reflow' phenomenon. Depletion of the
CSF around the ischemic spinal cord significantly pre-
vented paraplegia and associated pathological changes
(group 2). Depletion of the CSF creates a partially CSF free
environment in the ischemic spinal cord region. Although
depletion of the CSF does not eliminate ISF, it limits the
extent to which the ISF can be replenished from the CSF
and limits occurrence of edema. It is estimated that the
total volume of CSF is about 2.3 ml or 0.67 ml/kg for an
adult rabbit, and the CSF production rate is reportedly to
be between 7.8–8.8 µl/minute [16-18]. We were only able
to remove 0.8–1.2 ml CSF. We believe that the remainder
of the CSF may reside inside the cranium as we took sev-
eral steps to approximate the CSF free environment in the
ischemic spinal cord region. The depletion of CSF also
reduced the ICP to 0 mmHg. Therefore, in group three, we
tested the presence of the CSF around the ischemic spinal
cord while maintaining a 0 mmHg ICP. This allowed us toCerebrospinal Fluid Research 2005, 2:7 http://www.cerebrospinalfluidresearch.com/content/2/1/7
Page 7 of 12
(page number not for citation purposes)
Transverse sections of rabbit lumbar spinal cord after 1 h ischemia (H&E stain) Figure 2
Transverse sections of rabbit lumbar spinal cord after 1 h ischemia (H&E stain). A. Histopathological score 3, from 
a rabbit of Group 1. Severe necrosis destroys the entire structure of grey matter indiscriminately. B. Histopathological score 1, 
from a rabbit of Group 2. No apparent spinal cord damage, the grey matter is well preserved. C. Higher magnification of B 
showing normal morphology of grey matter and neurons. D. Histopathological score 2, from a rabbit of Group 3. The grey 
matter is lightly stained with many vacuolations of the neuropil. E. Higher magnification of D. Marked vacuolations of the 
neuropil in the grey matter, and some neurons are triangular with darkly stained shrunken nuclei (arrow).Cerebrospinal Fluid Research 2005, 2:7 http://www.cerebrospinalfluidresearch.com/content/2/1/7
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Transverse sections of rabbit lumbar spinal cord to show the microcirculation after 1 h of ischemia and 23 h reperfusion,  revealed by FITC-albumin Figure 3
Transverse sections of rabbit lumbar spinal cord to show the microcirculation after 1 h of ischemia and 23 h 
reperfusion, revealed by FITC-albumin. A. No CSF removed (Group 1) – the spinal cord demonstrates extremely faint 
fluorescein signal with absence of capillary filling in both grey matter and white matter, indicating a 'no-reflow' phenomenon. B. 
Depletion of the CSF (Group 2) – spinal cord section demonstrates intensive fluorescein signals, which are much stronger in 
grey matter than in white matter, indicating good blood perfusion. C. Replenishment of the CSF (Group 3) – grey matter dem-
onstrates faint fluorescein signal similar to white matter, indicating a marked blood perfusion deficit, i.e. 'low-reflow' phenome-
non. D. Albumin-modified artificial CSF replacement (Group 4), and E. Gelatin-modified artificial CSF replacement (Group 5) – 
capillary filling in both grey matter and white matter are clearly demonstrated by good fluorescein signal, albeit slightly less than 
that of Group 2, indicating some preservation of blood perfusion.Cerebrospinal Fluid Research 2005, 2:7 http://www.cerebrospinalfluidresearch.com/content/2/1/7
Page 9 of 12
(page number not for citation purposes)
Overview of mechanisms underlying the CNS vulnerability to ischemia Figure 4
Overview of mechanisms underlying the CNS vulnerability to ischemia. Blood brain barrier and Blood-CSF barrier 
determine the low protein concentration in the cerebrospinal fluid and the interstitial fluid. A large amount of free fluid causes 
the CNS cells to consume more energy to maintain normal intracellular environment. The positive intracranial pressure facili-
tates the edema formation. Edema results in 'no-reflow' phenomenon.Cerebrospinal Fluid Research 2005, 2:7 http://www.cerebrospinalfluidresearch.com/content/2/1/7
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examine the role of CSF without the influence of ICP. The
data demonstrated that the CSF itself is detrimental to
ischemic spinal cord.
Using albumin-modified artificial CSF to replace the CSF
significantly prevented paraplegia even when the ICP was
maintained within the physiological range. These data
indicate that detrimental effect of the CSF may be largely
ascribed to its low protein concentration. A high concen-
tration of protein present in artificial CSF not only pro-
vides limited free fluid to ISF, but may also increase the
protein concentration in ISF resulting in reduced amount
of the free fluid in interstitium. The increase of protein
concentration in ISF was less likely to result in volume
expansion in the interstitium because of the protein con-
centration gradient between the CSF and the ISF; any ISF
volume increase would be transferred to the protein-mod-
ified artificial CSF. We believe that the ultimate reason
why protein is important for the extracellular environ-
ment may be due chiefly to its water and ion binding
capacity. The water binding capacity for albumin is so
large that it is estimated that one gram of albumin can
bind 18 ml of water [19,20]. A number of physiological
functions have been reported for albumin, such as an anti-
inflammatory effect [21,22]. However, these alternative
functions are less likely to be the cause of the beneficial
effect because gelatin, which is mainly comprised of dena-
tured proteins, was equally neuroprotective. Although the
albumin and gelatin are both colloid osmotic agents, their
efficacies in preventing the spinal cord damage were not
likely to be due to their molecular weight, as we found
that other colloid osmotic agents, such as 10% Dextran
(molecular weight 40, 000–70,000 daltons) and 6% Het-
astarch (molecular weight 400,000–550,000 daltons)
which were known to create similar colloidal osmotic
pressure were ineffective (Y. Wang, unpublished observa-
tions). In addition to low protein concentration, many
nutrients are also lower in the CSF. For examples, the CSF
contains about two third of plasma glucose concentration
(CSF: 61 mg/dl; plasma: 92 mg/dl), and it contains about
one fifteenth of plasma insulin concentration (CSF: 4 µU/
ml; plasma: 20–30 µU/ml) [23-25]. Harkness and co-
workers showed that the adenosine 5'-triphosphate (ATP)
concentration was about 1 to 20 µmol/l in plasma, how-
ever, it was not measurable in the CSF [26]. Muñoz and
co-workers reported that the ATP concentration in CSF is
only about 16 nM/l [27]. Therefore, additional studies are
needed to examine if the deficiency of these nutrients in
normal CSF or the presence of any other microconstitu-
ents in CSF, may also contribute to vulnerability of the
CNS.
Rabbits with albumin- or gelatin-modified artificial CSF
replacement maintained with a physiological ICP still
showed ~20% paraplegic rate, while depletion of the CSF
showed 0% paraplegic rate, although the difference was
not statistically significant by Fisher exact test. The effect
of depleting the CSF may be partially due to ICP
reduction, and the 20% paraplegic rate may be explained
by the presence of physiological ICP. Elevated ICP has
been known to be clinically detrimental. For example,
CSF drainage has been used for almost 50 years to prevent
paraplegia during aortic surgery when the aorta needs to
be cross-clamped [28,29]. While this approach has been
reported to be effective in many studies [30-38], in some
examples positive outcomes were not achieved [39-41].
Crawford et al performed a randomized clinical study
using CSF drainage in 98 patients that underwent cross-
clamping of the aorta during surgery [39]. They controlled
the ICP at 10–15 mmHg while draining the CSF, and did
not find this approach effective in preventing paraplegia.
We believe that this negative outcome might be attributed
to the normal level of ICP and a large amount of CSF
remaining in the ischemic areas of the spinal cord. These
clinical outcomes in conjunction with our studies indicate
that both the presence of CSF and physiological ICP are
detrimental to ischemic spinal cord. The presence of CSF
may be a fundamental issue.
Our experiments demonstrated a clear 'no-reflow' and
'low-reflow' phenomenon, which was accompanied by
paraplegia and histopathological damage in the spinal
cord. Depletion of the CSF or replacement with albumin-
or gelatin-modified artificial CSF prevented the 'no-
reflow' phenomenon, associated motor function deficit
and histopathological spinal cord damage. Although
many investigators reported blood perfusion deficits fol-
lowing brain and spinal cord injuries [42-44], the mecha-
nism was not clear. Our findings suggest that this post-
ischemia deficit in blood perfusion may be linked, at least
in part, to the CSF associated edema and collapsing of
blood vessels in the Vichow-Robin space. This blood
perfusion deficit likely blocks collateral circulation and
induces a feedback loop contributing irreversible cell
death and tissue necrosis (Fig 4).
It has been shown that just 25 minutes of spinal cord
ischemia in this rabbit model is enough to cause perma-
nent paraplegia [10,15]. In our experiments, depletion of
the CSF prevented spinal cord damage after 1 h of
ischemia. With the extension of the ischemic period to 2
h, there was still significant protection of the spinal cord
(group 6). Permanent damage of the spinal cord was only
seen after 3 h of ischemia (group 7). These results indicate
that a greater level of resistance to ischemic injury can be
conferred to the spinal cord in a transiently CSF-free
environment.Cerebrospinal Fluid Research 2005, 2:7 http://www.cerebrospinalfluidresearch.com/content/2/1/7
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Conclusion
In summary, our findings suggest that the extracellular
environment, consisting of a low protein concentration in
the CSF and the ISF and a positive interstitial pressure,
may determine the vulnerability of CNS to ischemia. This
study has determined that depletion of the CSF or replac-
ing the CSF with albumin-, or gelatin-modified artificial
CSF in combination with a lowered ICP, provides protec-
tion in the setting of ischemic injury to the CNS.
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